Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | ILMN | ROIV | ||
| Company | Horizon Therapeutics | Illumina Inc | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 193.92 | 35.61 | ||
| High | 116.38 | 196.66 | 35.61 | ||
| Low | 116.26 | 189.09 | 35.07 | ||
| Latest | 116.30 | 191.56 | 35.58 | ||
| Change | +0.05 | -2.77 | +0.19 | ||
| % Change | +0.04% | -1.43% | +0.54% | ||
| Volume | 28,881,200 | 424,881 | 587,935 | ||
| 20-Day Average Volume | 3,994,490 | 1,946,103 | 6,143,310 | ||
| Previous Close | 116.25 | 194.33 | 35.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 171.52 | 32.27 | ||
| 20-Day Raw Stochastic | 95.09% | 86.32% | 93.83% | ||
| 20-Day Relative Strength | 80.29 | 68.31 | 70.15 | ||
| Weighted Alpha | +49.30 | +103.49 | +198.60 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +5.49% since 06/29/26 | +2.02% since 06/29/26 | ||
| Low | 115.66 on 09/29/23 | 174.78 on 06/30/26 | 34.58 on 07/02/26 | ||
| High | 116.38 on 10/05/23 | 196.66 on 07/07/26 | 35.90 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +17.69% since 06/05/26 | +23.97% since 06/05/26 | ||
| Low | 114.75 on 09/11/23 | 155.55 on 06/09/26 | 28.28 on 06/08/26 | ||
| High | 116.38 on 10/05/23 | 196.66 on 07/07/26 | 35.90 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +51.09% since 04/07/26 | +27.68% since 04/07/26 | ||
| Low | 98.80 on 08/03/23 | 118.30 on 04/10/26 | 27.06 on 04/24/26 | ||
| High | 116.38 on 10/05/23 | 196.66 on 07/07/26 | 35.90 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +27.24% since 01/07/26 | +61.19% since 01/07/26 | ||
| Low | 90.56 on 05/16/23 | 112.65 on 02/12/26 | 20.98 on 02/02/26 | ||
| High | 116.38 on 10/05/23 | 196.66 on 07/07/26 | 35.90 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 29,402,130 | 25,454,964 | ||
| Shares Outstanding, K | 228,995 | 151,300 | 719,270 | ||
| Annual Sales | 3,629,040,000 | 4,343,000,000 | 8,260,000 | ||
| Annual Net Income | 521,480,000 | 850,000,000 | -299,770,000 | ||
| Last Quarter Sales | 944,960,000 | 1,091,000,000 | 2,520,000 | ||
| Last Quarter Net Income | 127,070,000 | 134,000,000 | 302,990,000 | ||
| 60-Month Beta | 1.03 | 1.47 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 1.15 on 04/30/26 | -0.36 on 05/20/26 | ||
| Earnings Date | 11/01/23 | 07/30/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 37.51 | 0.00 | ||